• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XPT SARS-COV-2 IGG (SCOVG); SARS-COV-2 IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XPT SARS-COV-2 IGG (SCOVG); SARS-COV-2 IMMUNOASSAY Back to Search Results
Model Number N/A
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/28/2021
Event Type  malfunction  
Manufacturer Narrative
An outside of the united states (ous) customer contacted the siemens customer care center to report an observation of a positive (reactive) advia centaur xpt sars-cov-2 igg (scovg) result that was discordant to alternate test methods.The limitations section of the instructions for use state: "results are not intended to be used as the sole basis for patient management decisions.Test results should be interpreted in conjunction with clinical observations, patient history, epidemiological information, and other laboratory findings." "it is currently unknown how long sars-cov-2 antibodies persist following infection and if the presence of antibodies confers protective immunity." a false positive/reactive result would not be used in isolation and would be correlated with clinical history.At this time, the presence of an immune response cannot be interpreted as confirmation of immunity.Thus, continued precautions to avoid infection will occur with negligible clinical impact.Although there is no potential for serious injury in this case, an mdr will be reported to the fda as a requirement of the emergency use authorization (eua).Siemens is investigating.
 
Event Description
A customer reported a positive (reactive) advia centaur xpt sars-cov-2 igg (scovg) result that was discordant to alternate methods.The customer indicated that the initial result was provided to the physician and were questioned and that a corrected report was issued.There are no reports of patient intervention or adverse health consequences due to the positive (reactive) scovg result.
 
Manufacturer Narrative
Siemens healthcare diagnostics filed mdr 1219913-2021-000524 initial report on 2021-12-30.Additional information - 2022-04-18.Siemens has concluded investigation for a customer observation of a positive (reactive) advia centaur xpt sars-cov-2 igg (scovg) result with lot 012 that was discordant to alternate methods.Complaint lot 012 has since expired, therefore further testing cannot be performed.For the alleged false positive advia centaur xpt scovg sample result, data provided was inconclusive to whether the sample was reactive on scovg as the numeric result indicated a reactive result, but the interpretation provided by the customer was negative.The sample was not repeated on the scovg assay.As per the advia centaur xpt scovg ifu limitations section, "results are not intended to be used as the sole basis for patient management decisions.Test results should be interpreted in conjunction with clinical observations, patient history, epidemiological information, and other laboratory findings." siemens's internal data was reviewed for scovg lot 012 and all specifications were being met.No product non conformance has been identified.In section h6, investigation finding and investigation conclusion codes were updated based on the investigation results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XPT SARS-COV-2 IGG (SCOVG)
Type of Device
SARS-COV-2 IMMUNOASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
333 coney street
east walpole MA 02032
Manufacturer Contact
stacy loukos
333 coney street
east walpole, MA 02032
3392064073
MDR Report Key13118156
MDR Text Key289762928
Report Number1219913-2021-00524
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
EUA202670
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/30/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/17/2022
Device Model NumberN/A
Device Catalogue Number11207376
Device Lot Number012
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/18/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/25/2021
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-